SCHEMBL27075640

SCHEMBL27075640

Clc1cccc(Nc2c(-c3ccncn3)[nH]c3cnccc23)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.50
▸ TDO2 P48775 1/20 0.50
▸ ERBB2 P04626 2/20 0.46
▸ PTK6 Q13882 2/20 0.46
▸ EIF2AK2 P19525 2/20 0.44
▸ PIM1 P11309 3/20 0.43
▸ PIM2 Q9P1W9 3/20 0.43
▸ EGFR P00533 3/20 0.43
▸ ABL1 P00519 2/20 0.43
▸ BCR P11274 1/20 0.43
▸ PRKCA P17252 1/20 0.43
▸ PRKCD Q05655 1/20 0.43
▸ ABL2 P42684 1/20 0.43
▸ CHUK O15111 1/20 0.40
▸ CDK4 P11802 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ FADS1 O60427 3/20 0.39
▸ BUB1 O43683 1/20 0.39
▸ LCK P06239 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27075653 0.84 IDO1 (0.53) IDO1TDO2ERBB2PIM1EGFR
SCHEMBL27075643 0.84 BUB1 (0.52) IDO1TDO2ERBB2PTK6PIM1
SCHEMBL27075637 0.82 IGF1R (0.45) EIF2AK2EGFRCHUKROCK2
SCHEMBL27075647 0.70 BUB1 (0.53) ABL1BCRBUB1PTGS1PTGS2
SCHEMBL4785768 0.69 FADS1 (0.71) IDO1TDO2PIM1PIM2FADS1
SCHEMBL27075642 0.69 CHUK (0.45) IDO1TDO2PIM1PRKCAPRKCD
SCHEMBL27075648 0.69 CHUK (0.45) IDO1TDO2PIM1CHUK
SCHEMBL27215791 0.68 PIM1 (0.51) ERBB2PTK6PIM1PIM2EGFR
SCHEMBL13051120 0.68 ABL1 (0.58) EIF2AK2EGFRABL1BCRPRKCA
SCHEMBL3949696 0.68 HTR3E (0.59) IDO1TDO2ERBB2EGFRFADS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11891390-B1 3-substituted amino-2-arylpyrrolo[2,3-c]pyridines as CK2 inhibitors King Faisal University (SA) 2024-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11891390-B1 3-substituted amino-2-arylpyrrolo[2,3-c]pyridines as CK2 inhibitors CSNK2A3, CSNK2A2, CSNK2A1 IDO1 1592/4885TDO2 427/4885ERBB2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback